------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------DR.--------- JON ODORICO------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ AUGUST----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 9, 2004 AS PART OF A REPORT ON THE STATE OF EMBRYONIC-STEM CELL RESEARCH THREE----------- YEARS AFTER PRESIDENT BUSH LIMITED FEDERAL FUNDING FOR THE EFFORT, HEALTH----------- CORRESPONDENT SUSAN DENTZER TALKED WITH DR. JON ODORICO, A TRANSPLANT----------- SPECIALIST AND STEM-CELL RESEARCHER AT THE UNIVERSITY OF WISCONSIN.----------- THE FOLLOWING IS AN EXTENDED TRANSCRIPT OF THEIR DISCUSSION.------------------------------------------------------------- THE NEWSHOUR HEALTH UNIT IS FUNDED BY A GRANT FROM----------- THE HENRY J. KAISER FAMILY FOUNDATION.-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ONLINE NEWSHOUR SPECIALS-----------:---------------------------------------------------------------------------------------------------------------------------------- STEM----------------- CELL RESEARCH-------------------------------------------------------------------------------------------------------------------- ADULT----------------- STEM CELLS-------------------------------------------------------------------------------------------------------------------------------------------- EXTENDED----------------- INTERVIEWS---------------------------------------------------------------------------------------------------------------------------- DR.----------------- ELIAS ZERHOUNI----, DIRECTOR, NATIONAL INSTITUTES OF HEALTH----------------------------------------------------------------------------------------------------------------- DR.----------------- ZERHOUNI AND DR. RON MCKAY----, NATIONAL INSTITUTE OF NEUROLOGICAL----------------- DISORDERS AND STROKE-------------------------------------------------------------------------------------------------------------------- DR.----------------- JON ODORICO---- - UNIVERSITY OF WISCONSIN STEM CELL RESEARCHER-------------------------------------------------------------------------------------------------------------------- DR.----------------- JAMES THOMSON---- - UNIVERSITY OF WISCONSIN STEM CELL RESEARCHER--------------------------------------------------------------------------------------------------------------------- DR.----------------- YURI VERLINSKY----, DIRECTOR OF THE REPRODUCTIVE GENETICS INSTITUTE-----------------------------------------------------------------------------------------------------------------------------------U.S.----------------- REP. DAVE WELDON------------------------------------------------------------------------------------------------------------------------------ U.S.----------------- REP. DIANA DEGETTE---------------------------------------------------------------------------- PAST REPORTS:------------------------------------------------------------------------------------------------------------------------------------------------------ APRIL----------------- 8, 2002:------------------------------- FRED DE SAM LAZARO OF TWIN CITIES PUBLIC TELEVISION--------------------------------------------------------------------------- REPORTS----------------- ON STEM CELL RESEARCH IN INDIA----.--------------------------------------------------------------------- AUG. 10, 2001:------------------------------- A PANEL OF ETHICISTS AND MEMBERS OF THE SCIENTIFIC AND MEDICAL----------------- COMMUNITIES---------------------------------------------------------------------------- REACT----------------- TO THE PRESIDENT'S DECISION----.--------------------------------------------------------------------- APRIL 12, 2001:------------------------------- SCIENTISTS MAY HAVE FOUND A WAY TO USE------------------------------------------------------------------------------- HUMAN----------------- FAT AS A SOURCE OF ADULT STEM CELLS----.--------------------------------------------- MORE NEWSHOUR COVERAGE OF------------------------------------------------------------ HEALTH--------------------- AND-------------------------------------------------------------- SCIENCE--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- NEWS FOR STUDENTS:------------------------------------------------------------------------------------ FIRST----------------- STEM CELLS EXTRACTED FROM CLONED HUMAN EMBRYO----. 02.17.-----------------------------------------------04 LESSON PLAN----:--------------------------------------------------------------------------------------------------------- STEM----------------- CELL RESEARCH POLICY---- LESSON PLAN: CREATE AN ADVOCACY BROCHURE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- EMBRYONIC----------------- STEM CELL RESEARCH AT THE-UNIVERSITY OF WISCONSIN------------------------------------------------------------------------------------------------------ NIH----------------- HUMAN EMBRYONIC STEM CELL REGISTRY----------------------------------------------------------------------------------------------- REPRODUCTIVE----------------- GENETICS INSTITUTE-------------------------------------------------------------------------------------------------------------------------- STEM----------------- CELL FACT SHEET FROM THE WHITE HOUSE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SUSAN DENTZER: LET'S START BY TALKING ABOUT--------- YOUR LIFE AS A TRANSPLANT SURGEON, THE KINDS OF THINGS THAT YOU SAW THAT--------- GOT YOU INTO THIS ASPECT OF RESEARCH.---- DR. ODORICO: WELL, WE TRANSPLANT PANCREAS TRANSPLANTS AND ISLET CELL----------- TRANSPLANTS FOR PATIENTS WITH TYPE I DIABETES. AND ALTHOUGH THAT'S QUITE----------- SUCCESSFUL IN MANY CASES, AND PATIENTS CAN COME OFF INSULIN, WHICH THEY----------- NORMALLY NEED LIFELONG, THERE ARE MANY COMPLICATIONS THAT ARE ASSOCIATED----------- WITH THE TRANSPLANTS--SURGICAL COMPLICATIONS AND LONG-TERM COMPLICATIONS----------- WHICH CAN BE LIFE-THREATENING. PATIENTS HAVE TO TAKE IMMUNOSUPPRESSIVE----------- MEDICATIONS WHICH MAKE THEM MORE SUSCEPTIBLE TO INFECTIONS AND MALIGNANCIES----------- OR CANCERS ARE VERY COMMON AFTER TRANSPLANTATION, LONG TERM, UNFORTUNATELY-----------, WHICH REALLY CAN FORESHORTEN A PATIENT'S LIFE SPAN EVEN THOUGH THE ORGAN----------- MAY FUNCTION NORMALLY. SO, IN THIS, THESE ARE COMPLICATIONS THAT ARE----------- REALLY DEVASTATING TO SEE, NOT TO MENTION SOME TECHNICAL COMPLICATIONS -----------SHORTLY AFTER SURGERY.-----------------ALL THOSE TOGETHER ADD UP TO SOME PROBLEMS IN PANCREAS, AND KIDNEY-----------, AND ISLET TRANSPLANT PATIENTS THAT ENDS-UP BEING NOT A PERFECT TREATMENT----------- FOR THEM. SO THERE IS A PLUS SIDE AND A DOWNSIDE TO TRANSPLANTATION.----------- WE CERTAINLY EFFECTIVELY TREAT MANY PATIENTS, BUT THERE ARE SOME PATIENTS----------- WHO DON'T-DO VERY WELL, SO WE'RE LOOKING FOR BETTER TREATMENTS.---------------- IN ADDITION, THERE'S A SHORTAGE OF-PANCREAS ORGANS OR ORGANS IN GENERAL----------- FROM CADAVER DONORS, AND IT-DOESN'T MEET THE NEED OF ALL THE TYPE I----------- DIABETICS IN THIS COUNTRY.---------------- SUSAN DENTZER: SO, WHEN DID YOU FIRST SAY TO YOURSELF,----- "THERE MUST----------- BE A BETTER WAY, AND THAT WAY MAY HAVE SOMETHING TO DO WITH STEM CELLS-----"?---------------- DR. ODORICO: IN 1995, JAMIE THOMPSON, AT THE UNIVERSITY-OF WISCONSIN----------- HERE, DERIVED RHESUS OR MONKEY EMBRYONIC STEM CELLS. AND IT OCCURRED----------- TO US AT THAT TIME THAT, BECAUSE OF THE INCREDIBLE PROPERTIES OF EMBRYONIC----------- STEM CELLS BEING ABLE TO DIFFERENTIATE INTO MANY DIFFERENT CELL TYPES----------- OF THE BODIES AND TISSUES, THAT THIS MIGHT BE A POTENTIAL SOURCE FOR----------- ORGANS FOR TRANSPLANTATION IN THE FUTURE.---------------- SUSAN DENTZER: SO YOU LITERALLY THOUGHT, WOW, ORGAN SUPPLY.---------------- DR. ODORICO: IMMEDIATELY. IMMEDIATELY, AS DID MANY OTHERS. THERE ARE----------- OTHER ATTRIBUTES OF THE CELLS THAT REALLY ARE IMPORTANT TO UNDERSTANDING----------- DEVELOPMENTAL BIOLOGY MECHANISMS AND HOW TISSUES, AND ORGANS, AND OUR----------- BODIES FORM FROM SINGLE CELLS AND EARLY EMBRYOS, AND THERE ARE SOME----------- VERY IMPORTANT ROLES OF EMBRYONIC STEM CELLS AND FINDING OUT BASIC BIOLOGY-----------, BUT ALSO THERE IS THE APPLICATION OF EMBRYONIC STEM CELLS TO ACTUALLY----------- TREATING PATIENTS.---------------- SUSAN DENTZER: I DON'T WANT TO TRIVIALIZE THIS, BUT OF COURSE IN THE----------- POPULAR IMAGINATION--THIS HAS BECOME THE WAY PEOPLE THINK ABOUT IT--WOW-----------, ORGANS GROWING IN LAB DISHES. DID YOU ALMOST THINK THAT IN '95, THAT------------THAT WAS A POSSIBILITY?---------------- DR. ODORICO: ALMOST, YES, ALTHOUGH WE HAVE A LONG WAY TO GO YET TO----------- GET THERE, AND IT MIGHT BE A LITTLE BIT OF A STRETCH OF THE IMAGINATION----------- TO GO FROM SINGLE CELLS-TO A COMPLEX ORGAN. SO MANY APPLICATIONS OF----------- EMBRYONIC STEM CELLS FOR TREATMENT OF PATIENTS IS THOUGHT OF NOW AS----------- A CELL-BASED THERAPY. YOU MAKE THE EMBRYONIC STEM CELLS GROW INTO GROUPS----------- OF CELLS THAT HAVE A CERTAIN FUNCTION, AND THEN YOU TRANSPLANT THOSE----------- CELLS WITH AN INJECTION OF CELLS TO MAKE NEW FUNCTIONS IN THE PATIENT----------- TO RELAX FUNCTIONS OF THOSE PARTICULAR CELLS.---------------- AND THERE ARE MANY DISEASES IN HUMANS THAT ARE CHARACTERIZED BY THE----------- LOSS OF FUNCTION OF ONE OR A FEW DIFFERENT TYPES OF CELLS, AND THOSE----------- DISEASES COULD BE TREATED BY SOME STEM CELL-BASED THERAPY.---------------- SUSAN DENTZER: SO, IN '95, HOW QUICKLY DID YOU THINK THIS WOULD BECOME----------- A REALITY, THAT YOU'D ACTUALLY HAVE THERAPIES AVAILABLE FOR PATIENTS----------- BASED ON STEM CELLS?---------------- DR. ODORICO: WELL, MANY PEOPLE, INCLUDING MYSELF PERHAPS, THOUGHT----------- IT MIGHT BE JUST AROUND THE CORNER, MIGHT BE A FEW YEARS, BUT IT EVEN----------- TOOK 3 YEARS FOR DR. THOMPSON TO DERIVE HUMAN EMBRYONIC STEM CELLS.----------- AND THEN A FEW YEARS AFTER THAT, CERTAINLY MANY PEOPLE BECAME EXCITED----------- THAT TREATMENTS WERE JUST AROUND THE CORNER.---------------- BUT I REALIZE THAT, ALTHOUGH WE HAVE TO GIVE HOPE TO PATIENTS, I REALIZED----------- THAT IT WAS GOING TO BE A LONG PERIOD OF TIME. MEDICAL THERAPIES DON'T----------- HAPPEN OVERNIGHT. THEY EVOLVE A LOT OF BASIC SCIENCE RESEARCH NEEDED----------- TO BE DONE AND STILL NEEDS TO BE DONE, BUT THERE ARE PROMISING ASPECTS----------- OF THE RESEARCH ALREADY, AND SIGNIFICANT PROGRESS HAS BEEN MADE, SUCH----------- THAT I THINK IT'S VERY IMPORTANT TO KEEP GOING.----------------------------- SUSAN DENTZER: OKAY. YOU STARTED WORKING FIRST ON MOUSE EMBRYONIC STEM----------- CELLS. LET'S WALK THROUGH WHAT YOU DID. I'M NOW SPEAKING, OF COURSE-----------, ABOUT THE WORK THAT WAS PUBLISHED IN DIABETES. WHAT DID YOU DO? WHAT----------- DID YOU GET THE MOUSE STEM CELLS TO DO?---------------- DR. ODORICO: WELL, WE REALLY-MERELY OBSERVED WHAT THEY CAN DO. THEY----------- UNDERGO SPONTANEOUS DIFFERENTIATION AND CULTURE--MOUSE ES CELLS DO--AND----------- WE WANTED TO LOOK-FOR A PARTICULAR TYPE OF CELL THAT IS IMPORTANT FOR----------- PATIENTS WITH DIABETES, AND THAT IS ISLETS OF LANGERHANS, WHICH ARE----------- CLUSTERS OF HUNDREDS OF THOUSANDS OF CELLS THAT PRODUCE DIFFERENT HORMONES-----------, PARTICULARLY INSULIN, WHICH HELPS CONTROL BLOOD SUGARS.---------------- SO NO ONE HAD REALLY DONE THAT MUCH BEFORE WE BEGAN LOOKING, ALTHOUGH----------- OTHER CELL TYPES HAD BEEN DETECTED TO BE DIFFERENTIATED FROM MOUSE EMBRYONIC----------- STEM CELLS. SO WE WERE INTERESTED IN LOOKING FOR THIS PARTICULAR CELL----------- TYPE. UNFORTUNATELY, THE CELLS OF THIS TYPE ARE FAIRLY BLAND IN APPEARANCE-----------, AND THEY DON'T JUST JUMP AT YOU, SO WE HAD TO DO SOME GENE EXPRESSION----------- STUDIES OR LOOK FOR GENE EXPRESSION, LOOK FOR GENES TURNED ON, A PARTICULAR----------- TYPE AND LOOK FOR HORMONES PRODUCED AND DETECTED BY STAINING OF ANTIBODIES.---------------- SO--AND WE SAW THOSE IN THE CULTURES, IN THE PETRI DISHES, AS THE----------- CELLS GO THROUGH A VARIETY OF STAGES OF EMBRYONIC DEVELOPMENT, AND THEY----------- GO THROUGH STAGES OF EARLY PANCREAS TO MIDDLE PANCREAS, TO LATE PANCREAS----------- AND ACTUALLY INSULIN-PRODUCING CELLS UNDER THE CERTAIN CONDITIONS.---------------- SUSAN DENTZER: AND SO, IN EFFECT, YOU WATCHED AS THESE EMBRYONIC STEM----------- CELLS BECAME BETA CELLS, CORRECT?---------------- DR. ODORICO: CORRECT.---------------- SUSAN DENTZER: AND YOU DIDN'T DO ANYTHING MAGIC. YOU JUST WATCHED WHAT----------- NORMALLY HAPPENS IN AN EMBRYO, IN EFFECT.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: WAS THERE ANYTHING MAGIC ABOUT THE CULTURE THAT YOU WHIPPED----------- UP FOR THIS TO HAPPEN IN?---------------- DR. ODORICO: NO, THE CULTURE CONDITIONS WERE NOT VERY SPECIFIC OR----------- PARTICULAR. WE CULTURE THEM IN THE PRESENCE OF SERUM AND ALLOW THEM----------- TO FORM WHAT'S CALLED EMBRYOID BODIES. AND THESE EMBRYOID BODIES ARE----------- GROUPS OF CELLS THAT LOOK LIKE AN EMBRYO--AND THAT'S WHY THEY'RE CALLED----------- EMBRYOID BODIES--BUT THEY'RE NOT QUITE AN EMBRYO. THEY ARE ABNORMAL.----------- THEY'RE NOT NORMAL, BUT THEY HAVE MANY OF THE FEATURES OF EMBRYOS, AND----------- THAT'S WHY THEY'RE CALLED EMBRYOID BODIES.---------------- THEY-- GOING THROUGH THAT PHASE, AND THEN SUBSEQUENT, ALLOWING SUBSEQUENT----------- TO OCCUR, THEN YOU CAN BEGIN TO SEE SOME OF THE CELL TYPES: PANCREAT--------------------------------------------------------------------IC PRECURSOR CELLS, -----------INSULIN-PRODUCING CELLS.---------------- SUSAN DENTZER: AND WHAT, IN THE END, IS THE SIGNIFICANCE OF HAVING DEMONSTRATED----------- THIS OR HAVING WATCHED AS NATURE, IN EFFECT, DEMONSTRATED THIS IN MICE?---------------- DR. ODORICO: WELL, IT'S THE FIRST STEP REALLY TO GETTING TOWARDS A----------- THERAPY, AND THAT IS SHOWING THAT EMBRYONIC STEM CELLS CAN DIFFERENTIATE----------- OR CAN BECOME A PARTICULAR CELL TYPE THAT-PRODUCES INSULIN. THAT'S IMPORTANT----------- FOR POSSIBLY TREATING DIABETES IN THE FUTURE. THERE ARE MANY SUBSEQUENT----------- STEPS. WE HAVE TO SHOW THAT THEY FUNCTION AND SHOW THAT-THEY FUNCTION----------- IN ANIMALS, IN REVERSE DIABETES IN ANIMALS, AND THEN WE'D LIKE TO SHOW----------- THAT, IN PRECLINICAL MODELS, THESE CELLS MIGHT HAVE TREATMENT POTENTIAL.---------------- AND THEN ONE NEEDS TO SHOW THAT THEY ARE A SAFE TREATMENT, THAT THEY----------- DON'T FORM TUMORS AND THAT THEY'RE FREE OF INFECTION, RISK, AND THEN----------- ONE CAN THINK ABOUT SOME CLINICAL TRIALS OR TREATING PATIENTS IN AN----------- EXPERIMENTAL WAY.---------------- SUSAN DENTZER: SO YOU HAVEN'T CURED ANY MICE OF DIABETES YET.---------------- DR. ODORICO: NO, WE HAVEN'T. NO. AND WE DON'T KNOW WHO WELL THESE----------- CELLS FUNCTION. FOR INSTANCE, IF THEY'RE GOING THROUGH DIFFERENT PATHWAYS----------- OF DEVELOPMENT, IT MAY BE THAT SOME OF THEM ARE STUCK IN AN EARLY PATHWAY----------- OF IMMATURITY AND ARE NOT FULLY FUNCTIONAL, YET SOME OF THEM MAY HAVE----------- GONE THROUGH THAT WHOLE PATHWAY AND BECOME FULLY-FUNCTIONAL.-------------- BUT, CLEARLY, WE NEED TO LEARN ABOUT HOW BETTER TO GET THEM BECAUSE----------- ONLY A RARE FEW CELLS BECOME OF THIS TYPE OF PANCREATIC LINEAGE.---------------- SUSAN DENTZER: AND SOME BAIL OUT BEFORE THEY GET TO THAT STAGE.---------------- DR. ODORICO: SOME CHOOSE OTHER FATES, IN THAT THEY CHOOSE TO BECOME----------- HEART MUSCLE AND NEURONS OR MAYBE DON'T MAKE IT ALL THE WAY TOWARDS----------- INSULIN-PRODUCING ISLET CELLS. SO WE NEED TO FIGURE OUT OPTIMAL CULTURE----------- CONDITIONS TO STEER THEM OR DIRECT THEM--ALL THE CELLS, NOT JUST SOME----------- OF THEM--TO THE TYPE WE'RE INTERESTED IN.---------------- SUSAN DENTZER: AND WHAT WE UNDERSTAND, AT THE MOMENT, ABOUT WHY SOME----------- CELLS DIFFERENTIATE ONE WAY AND SOME THE OTHER WAY IS BASICALLY NOTHING-----------, CORRECT?---------------- DR. ODORICO: VERY LITTLE. VERY LITTLE. ONLY THE BEGINNINGS OF OUR----------- UNDERSTANDING OF DEVELOPMENTAL BIOLOGY, AND PARTICULARLY IN MICE AND----------- OTHER LESSER SPECIES, VERY LITTLE IN HUMANS.---------------- SUSAN DENTZER: LET'S STAY WITH THE MICE FOR A MOMENT. THE NEXT STAGE-----------, AS YOU SAY, WOULD BE TO ESSENTIALLY TRY TO TAKE SOME OF THESE CELLS----------- AND PUT THEM BACK INTO MICE THAT EITHER HAD DIABETES OR INDUCED TO HAVE----------- DIABETES AND SEE WHAT HAPPENS. WHEN WILL YOU DO THAT?---------------- DR. ODORICO: WELL, AT THIS POINT, SINCE IT'S SO FEW CELLS THAT PRODUCE----------- INSULIN, I THINK WE NEED TO GENERATE ENRICHED CULTURES FIRST--A LOT----------- OF CELLS PRODUCING INSULIN. AND THEN ONCE WE HAVE MANY OF THOSE IN HAND-----------, TEST THEIR FUNCTION IN A PETRI DISH AND THEM SIMULTANEOUSLY OR AT THE----------- SAME TIME PUT THEM INTO MICE AND SEE HOW THEY WORK, SEE IF THEY'RE ABLE----------- TO CURE DIABETES.---------------- SUSAN DENTZER: SO A MOUSE CURE COULD BE A COUPLE YEARS AWAY.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: PLUS.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: IF IT WORKS.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: AND IF THE MICE DON'T DEVELOP TUMORS.-------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: AND WE DON'T KNOW YET HOW TO GET THE CELLS TO TURN OFF----------- AND NOT MAKE TUMORS, CORRECT?---------------- DR. ODORICO: THAT IS A BIG CHALLENGE. I THINK THAT WOULD BE A SIGNIFICANT----------- CHALLENGE, BUT NOT INSURMOUNTABLE. WHEN YOU DIFFERENTIATE ES CELLS TO----------- CELLS THAT HAVE SPECIFIC FUNCTIONS, THEY LOSE SOME OF THE ABILITY TO----------- DIVIDE AND PROLIFERATE, WHICH IS WHAT TUMORS DO--TUMOR CELLS DO. SO-----------, IF YOU HAVE THOSE CELLS IN HAND AND THEY DON'T HAVE THAT ABILITY TO----------- PROLIFERATE, THEN THEY'RE LESS LIKELY TO DEVELOP TUMORS.---------------- THERE ARE ALSO GENETIC WAYS OF SELECTING OR KILLING OFF THE CELLS----------- THAT STILL HAVE TUMOR POTENTIAL, WHICH ARE THE UNDIFFERENTIATED ES CELLS----------- TO START WITH. ONCE THEY BECOME DIFFERENTIATED, THEY HAVE LESS-TUMOR----------- POTENTIAL, IT'S THOUGHT. AND I THINK,-SO THAT TUMOR POTENTIAL MAY BE----------- CONTROLLABLE, BUT STILL, FOR TREATMENT, IT'S OBVIOUSLY A VERY IMPORTANT----------- SAFETY ISSUE.---------------- SUSAN DENTZER: BECAUSE YOU-COULDN'T GUARANTEE TH--------------------------------------------------AT YOU MIGHT NOT TRANSPLANT ONE LOUSY CELL INTO-A MOUSE----------- THAT WOULD CREATE A TUMOR.---------------- DR. ODORICO: WELL, THERE WOULD BE--HAVE TO BE SOME STRICT SAFETY STANDARDS-----------, I THINK.---------------- SUSAN DENTZER: WHICH MEANS THAT WHEN IT COMES TO APPLYING THIS TO HUMANS-----------, WHAT?---------------- DR. ODORICO: IT MEANS DOING SOME PILOT STUDIES IN LARGER ANIMALS LIKE----------- RHESUS MONKEYS PERHAPS OR HUMAN MODELS THAT ARE APPLICABLE AND THEN----------- SHOWING SAFETY IN THAT SETTING BEFORE EVER TREATING A HUMAN.---------------- SUSAN DENTZER: SO, AGAIN--NOT TO DWELL ON THIS, BUT JUST SO THAT WE----------- CAN MAKE IT CLEAR TO THE PUBLIC HOW FAR AWAY THESE THERAPEUTIC APPLICATIONS----------- COULD BE, EVEN IF EVERYTHING GOES FABULOUSLY WELL, [IT COULD BE-----------] 10 YEARS MAYBE, MAYBE MORE, BEFORE YOU'RE ACTUALLY IN HUMAN TRIALS.---------------- DR. ODORICO: I THINK THAT'S REALISTIC. IF YOU HAD TO PUT A NUMBER----------- ON IT, ALTHOUGH, IN THIS BUSINESS, IT'S HARD TO PUT A NUMBER ON IT.-----------------SUSAN DENTZER: AND IF WE DID, SAY, A NUMERICAL SCALE, WHERE 100 IS A----------- THERAPY FOR HUMANS,-AND THAT'S THE STATE OF THE SCIENCE THAT WE HAVE----------- TO GET TO BEFORE WE'RE ACTUALLY ROUTINELY PROVIDING THIS THERAPY-TO----------- HUMANS, WHERE ARE WE ON THAT SCALE OF ZERO TO 100 AT THIS POINT?---------------- DR. ODORICO: I WOULD SAY WE'RE AT THE VERY EARLIEST STAGE, MAYBE-------------------- SUSAN DENTZER: NOW, RON REAGAN SAID LAST NIGHT IN HIS CONVENTION SPEECH-------------IMAGINE IF YOU COULD-HAVE A----- "BIOLOGICAL REPAIR KIT-----" ON DEPOSIT----------- AT YOUR LOCAL HOSPITAL OF YOUR OWN STEM CELLS. DOES THE PUBLIC HAVE----------- UNREALISTIC EXPECTATIONS AT THIS POINT ABOUT HOW QUICKLY ALL OF THIS----------- WILL PAN OUT?---------------- DR. ODORICO: WELL, FOR SOME DISEASES IT MAY BE CLOSER AT HAND. FOR----------- OTHER DISEASES, WE'RE STILL AT THE EARLIEST STAGES. FOR ALZHEIMER'S----------- DISEASE, IT MAY BE CHALLENGING BECAUSE WE DON'T KNOW A LOT ABOUT WHAT -----------CAUSES ALZHEIMER'S IN THE FIRST PLACE. FOR OTHER DISEASES, LIKE PARKINSON'S----------- DISEASE OR CARDIAC FAILURE, THERE ARE RELEVANT CELL POPULATIONS THAT----------- HAVE ALREADY BEEN DERIVED FROM HUMAN ES CELLS AND THAT FUNCTION WELL.---------------- AND EARLY ANIMAL MODELS ARE GOING ON NOW. EARLY ANIMAL STUDIES ARE----------- GOING ON NOW SUCH THAT I THINK THE APPLICATIONS IN THOSE SETTINGS MAY----------- BE SOONER BASED ON ROBUSTLY FUNCTIONING CELLS BEING DERIVED FROM HUMAN----------- ES CELLS.---------------- WHEREAS, ISLET TRANSPLANTATION INSTEAD FROM ES CELL-BASED THERAPY----------- IS PROBABLY A LITTLE BIT FARTHER AWAY BECAUSE WE HAVEN'T DEMONSTRATED-----------, NO ONE HAS DEMONSTRATED, FUNCTIONAL CELLS FROM HUMAN ES CELLS THAT ARE----------- ABLE TO CURE AN ANIMAL AT THIS STAGE.---------------- ON THE OTHER HAND, CELL-BASED THERAPIES IN GENERAL HAVE BEEN SHOWN----------- TO BE SUCCESSFUL IN PATIENTS WITH TYPE I DIABETES, AND WHAT I'M TALKING----------- ABOUT THERE IS HUMAN CADAVER DONOR, PANCREASES RECOVERED AND THEN ISLETS----------- ISOLATED FROM THEM AND THEN TRANSPLANTED TO TYPE I DIABETICS. AND THAT----------- CELL THERAPY WE KNOW WORKS.---------------- WHEREAS, IN PARKINSON'S DISEASE, ALZHEIMER'S DISEASE AND HEART FAILURE-----------, OTHER POTENTIAL APPLICATIONS FROM ES CELLS, WE DON'T KNOW WHETHER CELL-BASED----------- THERAPIES WILL HAVE A BENEFICIAL EFFECT. SO, IN THAT SENSE, THERE IS----------- A PRECEDENT FOR CELL-BASED THERAPIES THAT CAN BE ES CELLS AND ES CELL-DERIVED----------- ISLET TISSUE CAN BE IMMEDIATELY APPLIED TO HUMANS IF IT SHOWS TO BE----------- FUNCTIONAL.---------------- SUSAN DENTZER: SO THAT STRENGTHENS THE CASE FOR THIS THERAPY ACTUALLY----------- BEING APPLICABLE HERE.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: WHAT WORK ARE YOU DOING NOW ON HUMAN EMBRYONIC STEM CELLS----------- IN THIS LAB?---------------- DR. ODORICO: WELL, WE'RE WORKING ON A VARIETY OF FRONTS. ONE MAJOR----------- ONE IS TO FIND OPTIMAL CULTURE CONDITIONS WHICH ALLOW DIRECTED DIFFERENTIATION----------- OF HUMAN ES CELLS TO ISLET TISSUE.---------------- SUSAN DENTZER: AND BY----- "DIRECTED-----" YOU MEAN YOU WANT TO AIM----------- FOR ONE PARTICULAR TYPE OF CELL.---------------- DR. ODORICO: RIGHT.---------------- SUSAN DENTZER: YOU'RE ASKING WHAT CULTURE CONDITIONS DO YOU NEED TO----------- GET THE CELL TYPE YOU WANT.---------------- DR. ODORICO: EXACTLY. AND THAT SET OF CONDITIONS IS ELUSIVE RIGHT----------- NOW, AND MANY OTHER INVESTIGATORS AROUND THE COUNTRY ARE WORKING ON----------- THAT, AND THAT'S A MAJOR EFFORT RIGHT NOW, AND I THINK THE FIRST NEXT----------- STEP.---------------- OTHER THINGS WE'RE WORKING ON ARE USING GENETIC SELECTION METHODS----------- TO SELECT OUT THE CELL TYPES OF INTEREST FROM A HETEROGENOUS MIX OF----------- CELLS OR ENRICHING CULTURES BY SORTING CELLS.---------------- SUSAN DENTZER: HERE AT WISCONSIN YOU'RE WORKING ON AUTHORIZED LINES-----------, IN EFFECT, THE FIVE CELL LINES THAT HAVE BEEN DERIVED HERE. SO YOU DON'T----------- HAVE A PROBLEM. YOU'VE GOT A GOOD, STEADY IN-HOUSE SUPPLY OF STEM CELL----------- LINES. SO HAS THE PRESIDENT'S POLICY, AS ANNOUNCED IN AUGUST 2001, HAS----------- ANY OF THAT PRECLUDED ANY RESEARCH YOU MIGHT HAVE WANTED TO UNDERTAKE----------- OR HAVE YOU ESSENTIALLY BEEN IMMUNE TO THIS? HAVE YOU FELT ANY IMPACT----------- OF THIS POLICY IN A NEGATIVE WAY?---------------- DR. ODORICO: WE HAVE, YES, BECAUSE THERE ARE SOME EXPERIMENTS WE'D----------- LIKE TO DO WHICH WE ARE MORE CAUTIOUS ABOUT AND HAVE NOT UNDERTAKEN----------- YET, AND THAT IS SOME EXPERIMENTS WHICH WOULD--MIGHT BE CONDITIONS WHICH----------- MIGHT DRIVE THE CELLS TO A PARTICULAR TYPE OF CELL AND THE CELL TYPE----------- WE'RE INTERESTED IN.---------------- AND THOSE ARE BASIC DEVELOPMENTAL BIOLOGY STUDIES WHICH ALLOW CO-CULTURE----------- OR COMMINGLING OF EMBRYONIC TISSUES THAT MIGHT HAVE INDUCING OR DIRECTED----------- DIFFERENTIATION PROPERTIES, AND COMMINGLING THOSE TISSUES FROM EMBRYOS----------- WITH THE EMBRYONIC STEM CELLS OR PUTTING THE EMBRYONIC STEM CELLS IN----------- AN EMBRYO OF ANOTHER SPECIES AND SEEING WHAT THEY CAN BECOME IN THAT----------- SETTING.---------------- WE HAVEN'T UNDERTAKEN THOSE EXPERIMENTS BECAUSE OF THE QUESTIONS OF----------- INTRODUCING HUMAN ES CELLS INTO OTHER SPECIES' EMBRYOS.---------------- SUSAN DENTZER: SO JUST TO MAKE UP AN EXAMPLE, YOU MIGHT WANT TO TAKE----------- A HUMAN EMBRYONIC CELL AND ESSENTIALLY PUT IT INTO A MOUSE EMBRYO.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: AND YOU'RE NOT SURE IF YOU CAN DO THAT.---------------- DR. ODORICO: RIGHT.---------------- SUSAN DENTZER: BECAUSE?---------------- DR. ODORICO: BECAUSE OF THE FEDERAL REGULATIONS OF RESTRICTIONS ON----------- WHAT TYPES OF EXPERIMENTS ARE DONE WITH HUMAN ES CELLS. THEY'RE IN THE----------- RESTRICTIONS THAT YOU CANNOT INTRODUCE HUMAN ES CELLS INTO THE EMBRYO----------- OF A HUMAN OR ANOTHER SPECIES.---------------- SUSAN DENTZER: SO THAT'S------------------ DR. ODORICO: OFF LIMITS.---------------- SUSAN DENTZER: VERBOTEN.---------------- DR. ODORICO: YEAH.---------------- SUSAN DENTZER: SO THAT'S ANOTHER ASPECT OF THE PRESIDENT'S POLICY THAT----------- YOU WOULD WANT TO SEE CHANGED.---------------- DR. ODORICO: YES.---------------- SUSAN DENTZER: HAVE YOU ASKED THAT THAT BE DONE?---------------- DR. ODORICO: NO.---------------- SUSAN DENTZER: WHY?---------------- DR. ODORICO: THERE ARE MANY OTHER EXPERIMENTS TO WORK ON AT THIS POINT-----------, AND YOU KNOW WE HAVE TO LIVE WITHIN THE RESTRICTIONS, CURRENT RESTRICTIONS.----------- BUT I THINK IT WOULD BE A BENEFIT TO UNDERSTANDING BASIC DEVELOPMENTAL----------- BIOLOGY MECHANISMS AND UNDERSTANDING HOW TO DIRECT DIFFERENTIATION TO----------- CERTAIN CELL TYPES IF THOSE EXPERIMENTS COULD BE CARRIED OUT.---------------- SUSAN DENTZER: AND WHY WOULD-IT BE NECESSARY TO INTRODUCE THAT INTO----------- ANOTHER SPECIES TO DO THAT?---------------- DR. ODORICO: I THINK, ETHICALLY, I HAVE DIFFICULTY INTRODUCING HUMAN----------- ES CELLS INTO HUMAN EMBRYOS, AS MANY PEOPLE MIGHT, BUT OTHER EMBRYOS----------- OF OTHER SPECIES MIGHT HAVE INDUCTIVE PROPERTIES THAT REPRODUCE THAT----------- OF ALL EMBRYOS, AND IF PUT IN THE RIGHT TISSUE IN THE RIGHT LOCATION-----------, THE ES CELLS OF HUMANS MIGHT COMMUNICATE WITH THE CHEMICALS AND PROCESSES----------- THAT ARE GOING ON IN THE OTHER SPECIES' EMBRYOS. WE MIGHT WANT TO DO----------- THIS BECAUSE IT WOULD BE EASIER TO INTRODUCE THEM INTO EMBRYOS OF OTHER----------- SPECIES RATHER THAN HUMAN EMBRYOS.---------------- SUSAN DENTZER: ETHICALLY EASIER.---------------- DR. ODORICO: FOR ETHICAL REASONS.---------------- SUSAN DENTZER: LET'S ASSUME FOR THE MOMENT THE PRESIDENT'S POLICY STAYS----------- IN PLACE FOR AN UNKNOWN PERIOD OF TIME, BUT SOME TIME INTO THE FUTURE--FIVE-----------, MAYBE EVEN TEN YEARS--HOW MUCH WILL THAT HURT PROGRESS IN THIS, IN THE----------- FIELD OR WILL IT MAKE ANY DIFFERENCE? CAN YOU PROGRESS WITH THE EXISTING----------- CELL LINES?---------------- DR. ODORICO: I THINK IT WILL HURT PROGRESS BECAUSE SOME OF THE EXISTING----------- CELL LINES THAT WERE DERIVED IN 1998 ARE GETTING WORN OUT. AND WHAT----------- I MEAN BY THAT IS THEY'RE DEVELOPING CHROMOSOMAL ABNORMALITIES OR GENETIC----------- CHANGES, MUTATIONS THAT WILL AFFECT THEIR ABILITY, MIGHT AFFECT THEIR----------- ABILITY TO DIFFERENTIATE IN CELL TYPES ONE IS INTERESTED IN.---------------- IT MAY ALSO MAKE THEM HAVE A GREATER TUMOR POTENTIAL OR GREATER PROPENSITY----------- TO FORM TUMORS. SO I THINK THE CELLS THAT HAVE BEEN INTERMITTENTLY IN----------- CULTURE IN A PETRI DISH NOW FOR SIX YEARS ARE STARTING TO GET WORN OUT-----------, AND WE NEED FRESH CELLS, I THINK.-------------- SUSAN DENTZER: AND YOUR COLLEAGUE, JAMIE THOMSON, SAYS THAT THIS HAPPENS----------- WITH ALL TYPES OF CELLS. HE SAYS THAT IT IS AN ISSUE THAT IS OVERDONE-----------, EVEN IN THE SCIENTIFIC COMMUNITY, THAT THESE THINGS HAPPEN, AND YOU----------- CAN ALSO REGENERATE CELL LINES.-------------- DR. ODORICO: YES. ALL CELLS IN OUR BODY AGE AND SENESCE, EMBRYONIC STEM----------- CELLS ARE PARTICULARLY SPECIAL IN THAT CATEGORY BECAUSE THEY HAVE A----------- MUCH SLOWER AGING PROCESS AND DON'T SENESCE LIKE NORMAL CELLS IN ADULT--OUR----------- ADULT BODIES.-------------- THE--HOWEVER, GENETIC CHANGES CAN STILL OCCUR, AND THERE IS SELECTIVE----------- PRESSURE OF THE CELLS WHEN THEY'RE IN THE PETRI DISH WHICH CAN ALLOW----------- ABNORMAL CELLS TO HAVE A GROWTH ADVANTAGE AND OUTGROW THE NORMAL CELLS.----------- AND STARTING OUT WITH ONE CELL OVER TIME, YOU GET ALL THE CELLS-BECOMING----------- ABNORMAL.-------------- SO, EVEN IF THE CELLS DON'T AGE AS OTHER ADULT CELLS, SOMATIC CELLS----------- DO, YOU CAN STILL GET ABNORMAL CHANGES, AND THEY HAVE BEEN DOCUMENTED----------- ALREADY, AND I THINK THAT POSES A LONG-TERM PROBLEM, AND I THINK ULTIMATELY----------- SOME OF THE CELLS ARE GOING TO BE WORN OUT TO SUCH A DEGREE THAT THEY----------- BECOME UNUSABLE.---------------- SUSAN DENTZER: AND YOU CAN'T JUST GO BACK TO THE FREEZER AND GET THE----------- ORIGINAL STOCK OUT AND THAW THEM OUT AND START GROWING A NEW GENERATION?---------------- DR. ODORICO: WELL, YOU CAN GO BACK IN SOME CASES TO WHAT'S CALLED----------- AN EARLIER PASSAGE, YOUNGER CELLS, AND THAW THEM. HOWEVER, ONCE THOSE----------- GET USED UP, TOO--THERE'S ONLY A FINITE NUMBER OF THOSE--AND ONCE THOSE----------- ALL GET USED UP, WE'RE TALKING ABOUT USING CELLS WITH LATER AND LATER----------- PASSAGE, WHICH HAVE BEEN IN CULTURE IN A PETRI DISH FOR LONGER AND LONGER----------- PERIODS OF TIME, AND ULTIMATELY THERE HAVE TO BE CHANGES THAT OCCUR-----------, THERE'S NO DOUBT IN MY MIND, BECAUSE CULTURE CONDITIONS ARE ABNORMAL----------- CONDITIONS, AND SOME GENETIC CHANGES MIGHT EVEN--WOULD EVEN OCCUR IN----------- THE EMBRYO OR IN THE BODY.---------------- SO, OVER TIME, GENETIC CHANGES CAN OCCUR AND MUTATIONS CAN OCCUR-----------, AND ULTIMATELY I THINK THAT'S GOING TO BE A PROBLEM. SO WE NEED NEW----------- FRESH LINES TO REPLENISH THE OLDER, WORN-OUT ONES.----------------------------- SUSAN DENTZER: LET'S TALK ABOUT WHY YOU THINK IT MAY BE NECESSARY TO CREATE----------- INSULIN-PRODUCING PANCREATIC CELLS FROM HUMAN EMBRYONIC STEM CELLS.---------------- DR. ODORICO: IN THE U.S. ABOUT 1,500 PANCREAS TRANSPLANTS ARE DONE----------- EVERY YEAR AND, ON AN AVERAGE, ABOUT 100, IF THAT MANY, ISLET CELL TRANSPLANTS-------------50 TO 100 ISLET CELL TRANSPLANTS--BUT THAT'S GROWING EXPONENTIALLY.---------------- PANCREAS TRANSPLANTATION HAS A LITTLE FLATTER CURVE OF RISE OF NUMBERS------------ BUT YOU'RE TALKING ABOUT 30,000 NEW TYPE I DIABETICS OR MORE-EVERY YEAR----------- IN THE U.S, A MILLION TYPE I DIABETICS EXISTING, AND THE NUMBERS OF----------- ORGAN DONORS IN THE UNITED STATES, HUMAN CADAVER ORGAN DONORS IS ABOUT----------- 6,000 OR SO-----, 8,IT DOESN'T EVEN COME CLOSE TO MEETING THE NEED.---------------- SUSAN DENTZER: HOW MANY TYPE I PATIENTS WOULD NORMALLY PROGRESS TO THE----------- STATE THAT THEY WOULD NEED A TRANSPLANT?---------------- DR. ODORICO: IT DEPENDS ON HOW SEVERE THEY GET, BUT YOU COULD ARGUE----------- THAT ULTIMATELY ALL OF THEM WOULD BENEFIT FROM A TRANSPLANT BECAUSE----------- WHAT HAPPENS IS THAT THERE ARE-ACUTE LIFE-THREATENING EVENTS THAT CAN----------- OCCUR FROM LOW BLOOD SUGARS OR HIGH-BLOOD SUGARS THAT CAN CAUSE SEIZURES-----------, CAR ACCIDENTS, COMA, THAT CAUSE MORTALITY ACUTELY OR RAPIDLY, AND THOSE----------- CAN OCCUR IN ANYBODY--PARTICULARLY THOUGH IN-THE MORE BRITTLE TYPE I----------- DIABETICS.---------------- AND THEN MANY PATIENTS, BUT NOT ALL, GET CHRONIC PROBLEMS, LONG-TERM----------- PROBLEMS OF MANY YEARS OF HIGH BLOOD-SUGARS. IT AFFECTS OTHER ORGANS----------- LIKE THE EYES, HEART, BLOOD CIRCULATION, NERVES, AND-PARTICULARLY THE----------- KIDNEYS. SO PATIENTS HAVE MANY, MANY COMPLICATIONS, AND IT'S VERY COSTLY----------- FOR MEDICAL CARE. FOURTEEN PERCENT OF GNP IN SOME COUNTRIES IS SPENT----------- ON MEDICAL CARE FOR DIABETES, AND PARTICULARLY IN WESTERN COUNTRIES-----------, AND IT'S A DEVASTATING, VERY DEBILITATING DISEASE.-------------- AND IT'S NOT CLEAR WHICH PATIENTS AT THIS POINT--IT'S HARD TO PREDICT-----------, I SHOULD SAY, WHICH PATIENTS, OF ALL THE TYPE-I DIABETICS, WHAT PATIENTS----------- WILL GO ON TO SOME OF THESE PROBLEMS, BUT MANY OF THEM DO.---------------- SUSAN DENTZER: WHY, ETHICALLY, DO YOU THINK IT'S ALL RIGHT TO DO THIS----------- RESEARCH ON HUMAN EMBRYONIC STEM CELLS WHEN, CLEARLY, SOME PERCENT OF----------- THE POPULATION THINKS IT'S ANATHEMA? WHY DO YOU THINK IT'S NOT ANATHEMA?---------------- DR. ODORICO: WELL, I THINK THE PRINCIPLE OR THE REASON THEY SAY THAT----------- EMBRYONIC STEM CELL RESEARCH SHOULD NOT BE DONE IS BECAUSE THE EMBRYO----------- IS AN INDIVIDUAL OR A PERSON, AND THAT WOULD BE TANTAMOUNT TO KILLING----------- AN INDIVIDUAL PERSON.-------------- HOWEVER, AN EMBRYO, AND PARTICULARLY ES CELLS IN CULTURE, ARE NOT PEOPLE.----------- THEY MAY HAVE THE POTENTIAL TO BECOME AN INDIVIDUAL UNDER THE RIGHT----------- CONDITIONS, BUT IT'S THAT SEPARATION, THAT SEPARATING POTENTIAL FROM----------- WHAT IS, IS WHAT I THINK SEPARATES SOMETHING THAT SHOULD BE PROTECTED-----------, AS A HUMAN SUBJECT IS IN RESEARCH, VERSUS SOMETHING THAT DOESN'T DESERVE----------- THE SAME LEVEL OF PROTECTION FROM THE POINT OF VIEW OF RESEARCH.---------------- I LIKE TO USE THE ANALOGY OF THE ACORN AND THE OAK TREE. WE ALL BELIEVE----------- THAT WE SHOULD CONSERVE OAK TREES AND TREES IN GENERAL BECAUSE OF THEIR----------- BEAUTY, AND THEIR STATURE, AND THE GOOD THINGS THEY PROVIDE NATURE AND----------- US. AN OAK TREE COMES FROM AN ACORN. THERE ARE LOTS OF ACORNS RUNNING----------- AROUND THAT HAVE THE POTENTIAL TO-BECOME AN OAK TREE, YET WE DON'T GO----------- AROUND CONSERVING ACORNS. AND I THINK THAT'S WHY I THINK THAT IF-ES----------- CELLS REPRESENT THE ACORN IN THAT ANALOGY, THEN I DON'T THINK WE NEED----------- TO GO AROUND CONSERVING ES CELLS OR EMBRYOS THAT CAN BECOME ES CELLS.---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SUPPORT THE KIND OF JOURNALISM DONE BY THE NEWSHOUR...---------------------------------------------------------------BECOME A MEMBER OF YOUR LOCAL PBS STATION.------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------